Safety, tolerability and efficacy of lixisenatide as monotherapy in Japanese patients with type 2 diabetes mellitus: An open‐label, multicenter study

Publisher: John Wiley & Sons Inc

E-ISSN: 2040-1124|9|1|108-118

ISSN: 2040-1116

Source: Journal Of Diabetes Investigation, Vol.9, Iss.1, 2018-01, pp. : 108-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content